September 30 2021- RiverFort Provides €2M Convertible Facility to Fintech Health Technology Company.
In September 2021, RiverFort Global Capital arranged a convertible loan deal between Bioactive Bone Substitutes Oyj and RiverFort Global opportunities PCC Ltd. The facility had an aggregate commitment amount of up to €2,000,000 and a commitment period of 3 years. The initial commitment amount is between €500,000 – €750,000 with further tranches up to the aggregate commitment amount subject to mutual agreement. Funds were used towards achieving the CE-marking of the first product in addition to financing sales, marketing and operations.
